Apple to halt US sales of Series 9, Ultra 2 smartwatches on patent dispute
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
APPLE said on Monday (Dec 18) it would pause sales of its Series 9 and Ultra 2 smartwatches in the United States from this week, as it deals with a patent dispute over the technology that enables the blood oxygen feature on the devices.
The move comes after an order in October from the US International Trade Commission that could bar Apple from importing its Apple Watches after finding the devices violate medical technology company Masimo’s patent rights.
A presidential review period is in progress on the feature and while the review period will not end until Dec 25, Apple is preemptively taking steps to comply should the ruling stand, the company said.
The company said it would pause sales of the watches from its website starting Dec 21, and from Apple retail locations after Dec 24. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Singaporeans can now buy record amount of yen per Singdollar
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
StarHub hands Ensign InfoSecurity control back to Temasek in S$115 million deal, books S$200 million gain
